272 related articles for article (PubMed ID: 26092976)
1. Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia.
Devine RD; Bicer S; Reiser PJ; Velten M; Wold LE
Am J Physiol Heart Circ Physiol; 2015 Aug; 309(4):H685-91. PubMed ID: 26092976
[TBL] [Abstract][Full Text] [Related]
2. Minocycline attenuates cardiac dysfunction in tumor-burdened mice.
Devine RD; Eichenseer CM; Wold LE
J Mol Cell Cardiol; 2016 Nov; 100():35-42. PubMed ID: 27663174
[TBL] [Abstract][Full Text] [Related]
3. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
[TBL] [Abstract][Full Text] [Related]
4. Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting.
Shum AM; Mahendradatta T; Taylor RJ; Painter AB; Moore MM; Tsoli M; Tan TC; Clarke SJ; Robertson GR; Polly P
Aging (Albany NY); 2012 Feb; 4(2):133-43. PubMed ID: 22361433
[TBL] [Abstract][Full Text] [Related]
5. Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice.
Tian M; Asp ML; Nishijima Y; Belury MA
Int J Oncol; 2011 Nov; 39(5):1321-6. PubMed ID: 21822537
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.
El Hajj EC; El Hajj MC; Ninh VK; Gardner JD
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H463-H473. PubMed ID: 29775412
[TBL] [Abstract][Full Text] [Related]
7. [Myocardial matrix metalloproteinases activities in mice with viral myocarditis and their relationship with cardiac function and myocardial collagen amount].
Meng XH; Wang Y; Zhuang JX; Chen Y; Jin YP; Han XZ; Wang YL
Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):605-8. PubMed ID: 15347449
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived MMPs regulate cachexia in a Drosophila cancer model.
Lodge W; Zavortink M; Golenkina S; Froldi F; Dark C; Cheung S; Parker BL; Blazev R; Bakopoulos D; Christie EL; Wimmer VC; Duckworth BC; Richardson HE; Cheng LY
Dev Cell; 2021 Sep; 56(18):2664-2680.e6. PubMed ID: 34473940
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
10. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
Li YY; McTiernan CF; Feldman AM
Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
[TBL] [Abstract][Full Text] [Related]
11. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
Spinale FG; Coker ML; Bond BR; Zellner JL
Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit.
Romanic AM; Burns-Kurtis CL; Gout B; Berrebi-Bertrand I; Ohlstein EH
Life Sci; 2001 Jan; 68(7):799-814. PubMed ID: 11205871
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].
Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP
Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles.
Kherif S; Lafuma C; Dehaupas M; Lachkar S; Fournier JG; Verdière-Sahuqué M; Fardeau M; Alameddine HS
Dev Biol; 1999 Jan; 205(1):158-70. PubMed ID: 9882504
[TBL] [Abstract][Full Text] [Related]
15. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
Voloshenyuk TG; Gardner JD
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase inhibition and the prevention of heart failure.
Lee RT
Trends Cardiovasc Med; 2001 Jul; 11(5):202-5. PubMed ID: 11597832
[TBL] [Abstract][Full Text] [Related]
17. MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy.
Bobadilla M; Sáinz N; Rodriguez JA; Abizanda G; Orbe J; de Martino A; García Verdugo JM; Páramo JA; Prósper F; Pérez-Ruiz A
Stem Cells; 2014 Feb; 32(2):447-61. PubMed ID: 24123596
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.
Li YY; Feldman AM
Drugs; 2001; 61(9):1239-52. PubMed ID: 11511020
[TBL] [Abstract][Full Text] [Related]
19. Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig.
Goetzenich A; Hatam N; Zernecke A; Weber C; Czarnotta T; Autschbach R; Christiansen S
J Heart Lung Transplant; 2009 Oct; 28(10):1087-93. PubMed ID: 19782292
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection.
Tsukioka K; Suzuki Ji; Fujimori M; Wada Y; Yamaura K; Ito Ki; Morishita R; Kaneda Y; Isobe M; Amano J
Cardiovasc Res; 2002 Dec; 56(3):472-8. PubMed ID: 12445888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
